NewslettersCancer Stem Cell NewsExtracellular Matrix NewsHepatic Cell News TDP43 Promotes Stemness of Breast Cancer Stem Cells through CD44 Variant Splicing Isoforms By Ishira - May 4, 2022 0 Investigators found that loss of TAR DNA-binding protein-43 (TDP43) inhibited breast cancer stem cell stemness by reducing the abundance of cluster of differentiation 44 (CD44) variant alternative splicing isoforms. [Cell Death & Disease] Full Article